Prestige Consumer Healthcare (PBH) news

Canaccord Genuity cuts target price to C$117 from C$123 for Premium Brands Holdings Corp

Canaccord Genuity has adjusted its price target for Premium Brands Holdings Corp (PBH), lowering it to C$117 from C$123, while maintaining a Buy rating . The move reflects the firm’s ongoing confidence in the company’s long-term potential despite recent adjustments to its valuation expectations.…

Prestige Consumer Healthcare: expect acquisitions to become increasingly accretive to profitability, cash flow as we move past the near-term

Prestige Consumer Healthcare outlook FY adjusted EPS USD 4.55-4.65

Prestige Consumer Healthcare Inc: raising fiscal 2027 outlook to include acquisitions

Prestige Consumer Healthcare Inc. has raised its fiscal 2027 outlook, citing the recent acquisition of LaCorium Health and the successful pricing of a $400 million senior notes offering as key factors in the updated fiscal 2027 forecast . The company reported its first-quarter fiscal 2027 results…

PBH sees FY adj EPS $4.55 to $4.65, saw $4.42 to $4.51

Prestige Consumer Healthcare Inc. (PBH) has updated its fiscal 2027 earnings guidance, projecting adjusted diluted earnings per share (EPS) in the range of $4.55 to $4.65. This represents an upward revision from its previous outlook of $4.42 to $4.51. The company’s updated forecast reflects…